Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 376

1.

Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.

Zhang JC, Zhang HJ, Li Y, Jing D, Liu Q, Zhao K, Liu QQ, Zhuang Y, Kang WZ, Sun YT.

Scand J Infect Dis. 2013 May;45(5):368-77. doi: 10.3109/00365548.2012.744465. Epub 2012 Nov 28.

PMID:
23186319
2.

Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy.

Koblavi-Dème S, Maran M, Kabran N, Borget MY, Kalou M, Kestens L, Maurice C, Sassan-Morokro M, Ekpini ER, Roels TH, Chorba T, Nkengasong JN.

AIDS. 2003 Jul;17 Suppl 3:S17-22.

PMID:
14565605
3.

Assessment of CD8 T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Côte d'Ivoire.

Ondoa P, Koblavi-Dème S, Borget MY, Nolan ML, Nkengasong JN, Kestens L.

Clin Exp Immunol. 2005 Apr;140(1):138-48.

4.

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.

Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.

Cytometry B Clin Cytom. 2007 Jan 15;72(1):14-21.

5.

Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.

Resino S, Galán I, Bellón JM, Navarro ML, León JA, Muñoz-Fernandez MA.

J Clin Immunol. 2003 Jul;23(4):279-89.

PMID:
12959220
6.

Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.

Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):373-81.

PMID:
15764953
8.

CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.

Steel A, John L, Shamji MH, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.

HIV Med. 2008 Feb;9(2):118-25. doi: 10.1111/j.1468-1293.2007.00528.x.

9.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.

Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.

AIDS. 2000 Sep 8;14(13):1921-33.

PMID:
10997396
10.

Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.

Beran O, Holub M, Spála J, Kalanin J, Stanková M.

Acta Virol. 2003;47(2):121-4.

PMID:
14524479
12.

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.

Alatrakchi N, Duvivier C, Costagliola D, Samri A, Marcelin AG, Kamkamidze G, Astriti M, Agher R, Calvez V, Autran B, Katlama C.

AIDS. 2005 Jan 3;19(1):25-33.

PMID:
15627030
13.

Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years.

Arnó A, Ruiz L, Juan M, Zayat MK, Puig T, Balagué M, Romeu J, Pujol R, O'Brien WA, Clotet B.

AIDS. 1998 May 7;12(7):697-704.

PMID:
9619800
14.

HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.

Lubaki NM, Shepherd ME, Brookmeyer RS, Hon H, Quinn TC, Kashamuka M, Johnson M, Gottle R, Devers J, Lederman HM, Bollinger RC.

J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):19-30.

PMID:
10534143
16.

Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.

Tilling R, Kinloch S, Goh LE, Cooper D, Perrin L, Lampe F, Zaunders J, Hoen B, Tsoukas C, Andersson J, Janossy G; Quest Study Group.

AIDS. 2002 Mar 8;16(4):589-96.

PMID:
11873002
17.
18.

HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.

Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.

Antivir Ther. 2007;12(6):971-5.

PMID:
17926652
19.

Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.

Resino S, Abad ML, Navarro J, Bellón JM, Sánchez-Ramón S, Angeles Muñoz-Fernández M.

Clin Exp Immunol. 2003 Jan;131(1):130-7.

20.

HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.

Resino S, Galán I, Pérez A, León JA, Seoane E, Gurbindo D, Muñoz-Fernandez MA.

Clin Exp Immunol. 2004 Sep;137(3):570-7.

Items per page

Supplemental Content

Write to the Help Desk